Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Year: 2011
Type: article
Study design: Clinical Trial
Source: Annals of Hematology
Institutions: Armed Forces Capital Hospital, Seoul National University, National Cancer Center, Daegu Fatima Hospital, Gachon University Gil Medical Center, Samsung Medical Center, Asan Medical Center, Soonchunhyang University Hospital Seoul, Yonsei University, Severance Hospital, Ajou University Hospital, Korea Institute of Radiological and Medical Sciences, Ewha Womans University, Ewha Womans University Seoul Hospital, Inha University Hospital, Chung-Ang University Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2003527606